Delivery Order SPE2DB20D7059-SPE2DB24FQAB6

Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,629.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which was not set aside for any specific business type. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a potential value of $6,518.32 and a completion date of January 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $14,666.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGEML. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as Amerisourcebergen's primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $24,443.70 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order contract is issued under...
The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The $3,080.04 firm fixed-price contract has an ultimate completion date of August 26, 2024 and was not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will deliver the medical supplies to support various federal healthcare programs and facilities,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $12,110.08 contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a performance period through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $21,184.54 contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $24,443.70 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The delivery order is for BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 8, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger, single-award indefinite delivery contract (IDC) valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,027.52 firm fixed-price delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,104.16 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of February 28, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) awarded solely...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQAB6
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $31,405.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The performance period for this specific delivery order runs through March 1, 2024. No set-aside designation was used for this contract.

Generated 5/30/24, 9:47 AM